Healthy Volunteers Clinical Trial
Official title:
Validation of the Dynamometer LABIN
The main objective of this work is to validate the dynamometer LABIN in comparison with the
technique of gold-standard reference JAMAR, in a healthy population.
The infringement of the prehension is frequent and impacts on the social and professional
quality of life of the patients. There are numerous instruments measuring the strength of
prehension. The JAMAR is a mechanical, hydraulic dynamometer, exploring in kilograms the
maximal strength of the prehension. It is at present Gold Standard for the measure of the
strength of prehension. There is for the moment no electronic known instrument exploring the
endurance of the strength of prehension during an effort of tightening. This parameter would
indeed be interesting for the exploration in geriatrics and in the neuromuscular pathologies.
This study justifies itself by the fact that the dynamometer LABIN should allow the
evaluation of the muscular endurance of the strength of hand as complement of the peak of
strength
Measure of the strength of prehension with JAMAR and LABIN according to the following
protocol:
- Position: the subject sits comfortably on a chair without armrests, feet put on the
ground, the pond at the bottom of the seat, the hips and the knees in 90 ° of flexion,
shoulder in adduction and neutral rotation, the elbow bent in 90 °, forearm in neutral
position, the wrist between 0 and 30 ° of extension and between 0 and 15 ° of slope
ulnaire. The dynamometer is vertically presented and in front of the forearm to maintain
the standardized positions.
- Test: regulation of the zero by making a vacuous acquisition during 5 seconds. The order
"Jamar then Labin" or Labin then Jamar is chosen by randomization. The operator
encourages the subject to every test. The subject does not see the curve displaying.
- Test: 3 clampings of a handle of a dynamometer LABIN by the right hand during 5 seconds,
with a break of 30 seconds between the tests. After 2 minutes of break the subjects make
3 clampings with a left hand. After that , the same session is realized with the
dynamometer JAMAR
The order "Jamar then Labin" or Labin then Jamar is chosen by randomization. The operator
encourages the subject to every test. The subject does not see the curve displaying.
Total duration of participation in the study for the patient: 30 minutes
Main analysis: the calculation of the coefficient of correlation (Pearson or Spearman with
regard to the statistical distribution), coefficient of linen concordance and the coefficient
of intra-classy correlation.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
| Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
| Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
| Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
| Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
| Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
| Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
| Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
| Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
| Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
| Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
| Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
| Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
| Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
| Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
| Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
| Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
| Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |